Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation

Xiao-xiao Guo ab, Zhen-hu Guo c, Jing-song Lu c, Wen-sheng Xie c, Qiu-zi Zhong d, Xiao-dan Sun c, Xiu-mei Wang c, Jian-ye Wang *ab, Ming Liu *a and Ling-yun Zhao *c
aDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100730, China
bGraduate School of Peking Union Medical College, Beijing, 100730, China
cKey Laboratory of Advanced Materials, Ministry of Education of China, School of Materials Science and Engineering, Tsinghua University, Beijing, 100084, China
dDepartment of Radiotherapy, National Center of Gerontology, Institute of Geriatric Medicine, Beijing Hospital, Chinese Academy of Medical Science, Beijing, 100730, China

Received 8th April 2022 , Accepted 8th April 2022

First published on 25th April 2022


Abstract

Correction for ‘All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation’ by Xiao-xiao Guo et al., Nanoscale, 2021, 13, 14525–14537, https://doi.org/10.1039/D1NR03869A.


The authors regret that there was an error in the affiliation labels for Jian-ye Wang in the original manuscript. The correct affiliations are as shown herein.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2022
Click here to see how this site uses Cookies. View our privacy policy here.